CA2060994A1 - Electrical transdermal drug applicator with counteractor and method of drug delivery - Google Patents

Electrical transdermal drug applicator with counteractor and method of drug delivery

Info

Publication number
CA2060994A1
CA2060994A1 CA 2060994 CA2060994A CA2060994A1 CA 2060994 A1 CA2060994 A1 CA 2060994A1 CA 2060994 CA2060994 CA 2060994 CA 2060994 A CA2060994 A CA 2060994A CA 2060994 A1 CA2060994 A1 CA 2060994A1
Authority
CA
Canada
Prior art keywords
drug
counteractor
delivering
subject
applicator
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA 2060994
Other languages
French (fr)
Other versions
CA2060994C (en
Inventor
Dan Sibalis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Drug Delivery Systems Inc
Original Assignee
Drug Delivery Systems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Drug Delivery Systems Inc filed Critical Drug Delivery Systems Inc
Priority to CA 2060994 priority Critical patent/CA2060994C/en
Publication of CA2060994A1 publication Critical patent/CA2060994A1/en
Application granted granted Critical
Publication of CA2060994C publication Critical patent/CA2060994C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Electrotherapy Devices (AREA)
  • Medicinal Preparation (AREA)

Abstract

An electrical transdermal drug applicator provides enhanced drug flow to the bloodstream of the subject by delivering a primary drug into a subject's circulatory system for therapeutic purposes, and delivering from the same or other reservoir a non therapeutic counteracting agent to the skin of the patient which induces flow enhancement and allows delivery of the primary drug systemically over a longer period of time and in greater quantity than heretofore appeared possible using electric current.
CA 2060994 1992-02-11 1992-02-11 Electrical transdermal drug applicator with counteractor and method of drug delivery Expired - Fee Related CA2060994C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA 2060994 CA2060994C (en) 1992-02-11 1992-02-11 Electrical transdermal drug applicator with counteractor and method of drug delivery

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA 2060994 CA2060994C (en) 1992-02-11 1992-02-11 Electrical transdermal drug applicator with counteractor and method of drug delivery

Publications (2)

Publication Number Publication Date
CA2060994A1 true CA2060994A1 (en) 1993-08-12
CA2060994C CA2060994C (en) 2000-10-31

Family

ID=4149237

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2060994 Expired - Fee Related CA2060994C (en) 1992-02-11 1992-02-11 Electrical transdermal drug applicator with counteractor and method of drug delivery

Country Status (1)

Country Link
CA (1) CA2060994C (en)

Also Published As

Publication number Publication date
CA2060994C (en) 2000-10-31

Similar Documents

Publication Publication Date Title
Prausnitz The effects of electric current applied to skin: a review for transdermal drug delivery
HU9602356D0 (en) Drug targeting system, method for preparing same and its use
CA2181742A1 (en) Reduction of skin irritation during electrotransport delivery
GB9401891D0 (en) Therapeutic agents
TW286286B (en)
CA2307283A1 (en) Dual shock atrial defibrillation apparatus
WO1998020027A3 (en) Therapeutic use of an agent that stimulates no or prostacyclin production and delivery device
CA2251563A1 (en) Method for maintaining an existing level of body fat and/or body weight
EP1570823A3 (en) Substained analgesia achieved with buprenorphine
WO2001043749A3 (en) Pharmaceutical implant containing immediate-release and sustained-release components and method of administration
AU582075B2 (en) Medical device for pulsatile transdermal delivery of biologically active agents
WO2001012122A3 (en) Method and system for treating cardiac arrest using hypothermia
WO1996025947A3 (en) Induction of e-selectin for targetting therapeutic agents
WO2002036072A3 (en) Method for short-term and long-term drug dosimetry
WO2005000398A3 (en) Intravascular electrophysiological system and methods
EP0637946A4 (en) Tissue-specific implantable therapeutic agent delivery system.
WO2001030802A3 (en) Therapeutic treatments comprising administration of certain steroids for blood cell deficiencies
ZA985863B (en) Transdermal therapeutic system
MY103355A (en) Active substance-containing plaster of the controlled administration of active substances to the skin, the use thereof and a process for the controlled administration of active substances to the skin
UA66812C2 (en) Drug formulation with controlled release of active ingredient
ATE361772T1 (en) CONTAINER FOR IONTOPHORETIC ADMINISTRATION OF MEDICATIONS WITH INERT MATERIAL COMPONENTS
MY124465A (en) Reduction of infarct volume using citicoline
EP1561462A3 (en) Anti arrhytmic composition and methods of treatment
EP0175440A3 (en) Method of treating migraine headaches
ZA987006B (en) Transdermal therapeutic system (TTS) for delivering active ingredient through the skin to a body and method for application to the skin

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed